Lifecore Biomedical Inc
LFCR7.410USD
+0.420+6.01%
Fechamento 08/04, 16:00（ET）Cotações atrasadas em 15 min
274.36MValor de mercado
PerdaP/L TTM
Mais detalhes de Lifecore Biomedical Inc Empresa
Lifecore Biomedical, Inc. is a fully integrated contract development and manufacturing organization (CDMO). The Company designs, develops, manufactures and sells differentiated products for biomaterials markets and license technology applications to partners. The Company offers highly differentiated capabilities in the development, fill and finish of sterile, injectable-grade pharmaceutical products in syringes and vials. It is involved in the manufacture of pharmaceutical-grade sodium hyaluronate (HA) in bulk form, as well as formulated and filled syringes and vials for injectable products used in treating a spectrum of medical conditions and procedures. The Company uses its fermentation process and aseptic formulation and filling expertise to develop HA-based products for multiple applications and to take advantage of non-HA devices and drug opportunities.
Informações da empresa
Código da empresaLFCR
Nome da EmpresaLifecore Biomedical Inc
Data de listagemFeb 15, 1996
CEOMr. Paul Josephs
Número de funcionários524
Tipo de títulosOrdinary Share
Fim do ano fiscalFeb 15
Endereço3515 Lyman Boulevard
CidadeCHASKA
Bolsa de valoresNASDAQ Global Select Consolidated
PaísUnited States of America
Código postal55318
Telefone19523684300
Sitehttps://www.lifecore.com/
Código da empresaLFCR
Data de listagemFeb 15, 1996
CEOMr. Paul Josephs
Executivos da empresa
Nome
Nome/Posição
Posição
Ações detidas
Variação
Mr. Thomas (Tom) Salus
Mr. Thomas (Tom) Salus
Chief Legal and Administrative Officer , Corporate Secretary
Chief Legal and Administrative Officer , Corporate Secretary
240.98K
+12.08%
Mr. Paul Josephs
Mr. Paul Josephs
President, Chief Executive Officer, Director
President, Chief Executive Officer, Director
133.33K
+249.16%
Mr. Ryan David Lake
Mr. Ryan David Lake
Chief Financial Officer, Executive Vice President, Company Secretary
Chief Financial Officer, Executive Vice President, Company Secretary
97.12K
+76.82%
Ms. Katrina Lovas (Kathy) Houde
Ms. Katrina Lovas (Kathy) Houde
Independent Chairman of the Board
Independent Chairman of the Board
79.41K
+32.56%
Mr. Joshua E. Schechter
Mr. Joshua E. Schechter
Independent Director
Independent Director
79.17K
+32.69%
Mr. Jason M. Aryeh
Mr. Jason M. Aryeh
Independent Director
Independent Director
44.06K
+79.44%
Mr. Nelson Obus
Mr. Nelson Obus
Independent Director
Independent Director
19.51K
--
Ms. Jackie Klecker
Ms. Jackie Klecker
Executive Vice President - Quality and Development Services
Executive Vice President - Quality and Development Services
--
--
Mr. Christopher Kiper
Mr. Christopher Kiper
Independent Director
Independent Director
--
--
Mr. Humberto C. Antunes, M.D.
Mr. Humberto C. Antunes, M.D.
Independent Director
Independent Director
--
--
Ver Mais
Nome
Nome/Posição
Posição
Ações detidas
Variação
Mr. Thomas (Tom) Salus
Mr. Thomas (Tom) Salus
Chief Legal and Administrative Officer , Corporate Secretary
Chief Legal and Administrative Officer , Corporate Secretary
240.98K
+12.08%
Mr. Paul Josephs
Mr. Paul Josephs
President, Chief Executive Officer, Director
President, Chief Executive Officer, Director
133.33K
+249.16%
Mr. Ryan David Lake
Mr. Ryan David Lake
Chief Financial Officer, Executive Vice President, Company Secretary
Chief Financial Officer, Executive Vice President, Company Secretary
97.12K
+76.82%
Ms. Katrina Lovas (Kathy) Houde
Ms. Katrina Lovas (Kathy) Houde
Independent Chairman of the Board
Independent Chairman of the Board
79.41K
+32.56%
Mr. Joshua E. Schechter
Mr. Joshua E. Schechter
Independent Director
Independent Director
79.17K
+32.69%
Mr. Jason M. Aryeh
Mr. Jason M. Aryeh
Independent Director
Independent Director
44.06K
+79.44%
Detalhamento da receita
Moeda: USDAtualizado em: ter, 4 de mar
Moeda: USDAtualizado em: ter, 4 de mar
FY2023Q3
FY2023Q2
FY2023Q1
FY2022
FY2022Q4
FY2021
FY2020
FY2019
Por EmpresaUSD
Nome
Receita
Proporção
Contract development and manufacturing organization ("CDMO")
17.81M
64.53%
Fermentation
8.52M
30.87%
Olive oil and wine vinegars
1.27M
4.60%
Technology
0.00
0.00%
Por RegiãoUSD
Nome
Receita
Proporção
United States
16.40M
59.42%
Switzerland
6.80M
24.64%
Ireland
1.10M
3.99%
Australia
1.10M
3.99%
Canada
700.00K
2.54%
Other
1.50M
5.43%
Por Empresa
Por Região
Por EmpresaUSD
Nome
Receita
Proporção
Contract development and manufacturing organization ("CDMO")
17.81M
64.53%
Fermentation
8.52M
30.87%
Olive oil and wine vinegars
1.27M
4.60%
Technology
0.00
0.00%
Distribuição de ações
Atualizado em: sáb, 12 de jul
Atualizado em: sáb, 12 de jul
Investidores
Tipos de investidores
Investidores
Investidores
Proporção
Wynnefield Capital, Inc.
12.70%
Legion Partners Asset Management, LLC
11.97%
Greenhaven Road Investment Management, L.P.
9.77%
325 Capital LLC
5.84%
Laughing Water Capital, LP
5.13%
Other
54.59%
Investidores
Investidores
Proporção
Wynnefield Capital, Inc.
12.70%
Legion Partners Asset Management, LLC
11.97%
Greenhaven Road Investment Management, L.P.
9.77%
325 Capital LLC
5.84%
Laughing Water Capital, LP
5.13%
Other
54.59%
Tipos de investidores
Investidores
Proporção
Hedge Fund
28.40%
Investment Advisor
23.46%
Investment Advisor/Hedge Fund
18.13%
Individual Investor
2.05%
Research Firm
2.01%
Venture Capital
0.25%
Bank and Trust
0.12%
Insurance Company
0.02%
Other
25.54%
Participação acionária institucional
Atualizado em: ter, 1 de jul
Atualizado em: ter, 1 de jul
Período do relatório
N.º de instituições
Ações detidas
Proporção
Variação
2025Q2
211
27.29M
73.73%
-2.75M
2025Q1
229
29.94M
81.56%
-2.38M
2024Q4
243
30.30M
82.90%
-2.02M
2024Q3
234
26.35M
84.61%
-494.37K
2024Q2
224
23.91M
77.61%
-4.44M
2024Q1
225
24.56M
80.40%
-3.68M
2023Q4
221
23.64M
77.94%
-3.68M
2023Q3
229
20.71M
68.28%
-6.48M
2023Q2
237
20.72M
68.32%
-8.44M
2023Q1
244
23.24M
76.67%
-6.53M
Ver Mais
Atividade dos acionistas
Nome
Ações detidas
Proporção
Variação
Var. %
Data
Wynnefield Capital, Inc.
4.70M
12.7%
--
--
Mar 31, 2025
Legion Partners Asset Management, LLC
4.43M
11.97%
--
--
Mar 31, 2025
Greenhaven Road Investment Management, L.P.
3.62M
9.77%
--
--
Mar 31, 2025
325 Capital LLC
2.16M
5.84%
+1.37M
+172.80%
Mar 31, 2025
Laughing Water Capital, LP
1.90M
5.13%
+321.80K
+20.39%
Feb 18, 2025
David Capital Partners, LLC
1.80M
4.87%
+148.00K
+8.94%
Dec 31, 2024
BlackRock Institutional Trust Company, N.A.
1.63M
4.41%
+134.35K
+8.97%
Mar 31, 2025
The Vanguard Group, Inc.
1.55M
4.18%
+15.96K
+1.04%
Mar 31, 2025
Geode Capital Management, L.L.C.
750.50K
2.03%
+64.75K
+9.44%
Mar 31, 2025
Morgan Stanley & Co. LLC
617.00K
1.67%
-19.06K
-3.00%
Mar 31, 2025
Ver Mais
ETFs Relacionados
Atualizado em: sáb, 2 de ago
Atualizado em: sáb, 2 de ago
Nome
Proporção
Invesco Dorsey Wright SmallCap Momentum ETF
0.44%
iShares Micro-Cap ETF
0.05%
WisdomTree US SmallCap Fund
0.03%
Motley Fool Next Index ETF
0.02%
iShares Russell 2000 ETF
0.01%
Global X Russell 2000 ETF
0.01%
ProShares Hedge Replication ETF
0.01%
Proshares Ultra Russell 2000
0.01%
ProShares UltraPro Russell2000
0.01%
Invesco Russell 2000 Dynamic Multifactor ETF
0.01%
Ver Mais
Invesco Dorsey Wright SmallCap Momentum ETF
Proporção0.44%
iShares Micro-Cap ETF
Proporção0.05%
WisdomTree US SmallCap Fund
Proporção0.03%
Motley Fool Next Index ETF
Proporção0.02%
iShares Russell 2000 ETF
Proporção0.01%
Global X Russell 2000 ETF
Proporção0.01%
ProShares Hedge Replication ETF
Proporção0.01%
Proshares Ultra Russell 2000
Proporção0.01%
ProShares UltraPro Russell2000
Proporção0.01%
Invesco Russell 2000 Dynamic Multifactor ETF
Proporção0.01%
Dividendo
Um total de
0.00
USD foi distribuído em dividendos nos últimos 5 anos.
Data
Dividendo
Data de registro
Data de pagamento
Data ex-dividendo
Sem dados
Desdobramento de ações
Data
Tipo
Proporção
Sem dados
Data
Tipo
Proporção
Sem dados
